Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aimee J Varewijck

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Frontiers in Endocrinology|January 8, 2015
IGF-IR Targeted Therapy: Past, Present and FutureJoseph A M J L Janssen, Aimee J Varewijck
Frontiers in Endocrinology|June 7, 2014
Insulin analogs and cancer: a note of cautionJoseph A M J L Janssen, Aimee J Varewijck
Endocrine-Related Cancer|March 16, 2012
Insulin and its analogues and their affinities for the IGF1 receptorAimee J Varewijck, Joseph A M J L Janssen
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|September 8, 2019
The insulin-like growth factor-I receptor stimulating activity (IRSA) in health and diseaseJoseph A M J L Janssen, Aimee J Varewijck, Michael P Brugts
Diabetes|April 10, 2013
Concentrations of insulin glargine and its metabolites during long-term insulin therapy in type 2 diabetic patients and comparison of effects of insulin glargine, its metabolites, IGF-I, and human insulin on insulin and igf-I receptor signalingAimee J Varewijck, Hannele Yki-Järvinen, Ronald Schmidt, et al.
The Journal of Clinical Endocrinology and Metabolism|January 9, 2013
IGF-I bioactivity might reflect different aspects of quality of life than total IGF-I in GH-deficient patients during GH treatmentAimee J Varewijck, Steven W J Lamberts, Sebastian J C M M Neggers, et al.
The Journal of Clinical Endocrinology and Metabolism|January 9, 2013
Circulating IgGs may modulate IGF-I receptor stimulating activity in a subset of patients with Graves' ophthalmopathyAimee J Varewijck, Anita Boelen, Steven W J Lamberts, et al.
European Journal of Endocrinology|May 8, 2015
Changes in circulating IGF1 receptor stimulating activity do not parallel changes in total IGF1 during GH treatment of GH-deficient adultsAimee J Varewijck, Steven W J Lamberts, A J van der Lely, et al.
The Journal of Clinical Endocrinology and Metabolism|September 23, 2017
Serum Insulin Bioassay Reflects Insulin Sensitivity and Requirements in Type 1 DiabetesJoseph A M J L Janssen, Gemma Llauradó, Aimee J Varewijck, et al.
Molecular and Cellular Endocrinology|September 18, 2012
Circulating insulin-like growth factors may contribute substantially to insulin receptor isoform A and insulin receptor isoform B signallingAimee J Varewijck, Michael P Brugts, Jan Frystyk, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Frontiers in Endocrinology|January 8, 2015
IGF-IR Targeted Therapy: Past, Present and FutureJoseph A M J L Janssen, Aimee J Varewijck
Frontiers in Endocrinology|June 7, 2014
Insulin analogs and cancer: a note of cautionJoseph A M J L Janssen, Aimee J Varewijck
Endocrine-Related Cancer|March 16, 2012
Insulin and its analogues and their affinities for the IGF1 receptorAimee J Varewijck, Joseph A M J L Janssen
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|September 8, 2019
The insulin-like growth factor-I receptor stimulating activity (IRSA) in health and diseaseJoseph A M J L Janssen, Aimee J Varewijck, Michael P Brugts
Diabetes|April 10, 2013
Concentrations of insulin glargine and its metabolites during long-term insulin therapy in type 2 diabetic patients and comparison of effects of insulin glargine, its metabolites, IGF-I, and human insulin on insulin and igf-I receptor signalingAimee J Varewijck, Hannele Yki-Järvinen, Ronald Schmidt, et al.
The Journal of Clinical Endocrinology and Metabolism|January 9, 2013
IGF-I bioactivity might reflect different aspects of quality of life than total IGF-I in GH-deficient patients during GH treatmentAimee J Varewijck, Steven W J Lamberts, Sebastian J C M M Neggers, et al.
The Journal of Clinical Endocrinology and Metabolism|January 9, 2013
Circulating IgGs may modulate IGF-I receptor stimulating activity in a subset of patients with Graves' ophthalmopathyAimee J Varewijck, Anita Boelen, Steven W J Lamberts, et al.
European Journal of Endocrinology|May 8, 2015
Changes in circulating IGF1 receptor stimulating activity do not parallel changes in total IGF1 during GH treatment of GH-deficient adultsAimee J Varewijck, Steven W J Lamberts, A J van der Lely, et al.
The Journal of Clinical Endocrinology and Metabolism|September 23, 2017
Serum Insulin Bioassay Reflects Insulin Sensitivity and Requirements in Type 1 DiabetesJoseph A M J L Janssen, Gemma Llauradó, Aimee J Varewijck, et al.
Molecular and Cellular Endocrinology|September 18, 2012
Circulating insulin-like growth factors may contribute substantially to insulin receptor isoform A and insulin receptor isoform B signallingAimee J Varewijck, Michael P Brugts, Jan Frystyk, et al.
Pageof 2